Cargando…
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
Ischemic preconditioning (IP) is a powerful cardioprotective cellular mechanism that has been related to the “warm-up phenomenon” or “walk-through” angina, and has been documented through the use of sequential exercise tests (ETs). It is known that several drugs, for example, cromokalim, pinacidil,...
Autores principales: | Costa, Leandro M.A., Rezende, Paulo C., Garcia, Rosa M.R., Uchida, Augusto H., Seguro, Luis Fernando B.C., Scudeler, Thiago L., Bocchi, Edimar A., Krieger, Jose E., Hueb, Whady, Ramires, José Antonio F., Filho, Roberto Kalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616436/ https://www.ncbi.nlm.nih.gov/pubmed/26287407 http://dx.doi.org/10.1097/MD.0000000000001161 |
Ejemplares similares
-
Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
por: Rezende, Paulo Cury, et al.
Publicado: (2015) -
Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance
por: da Costa, Leandro Menezes Alves, et al.
Publicado: (2017) -
Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease
por: Rahmi, Rosa Maria, et al.
Publicado: (2013) -
Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease
por: Segre, Carlos Alexandre W., et al.
Publicado: (2023) -
Significant association of SYNTAX score on release of cardiac biomarkers in uncomplicated post-revascularization procedures among patients with stable multivessel disease: MASS-V Study group
por: de Azevedo, Diogo Freitas Cardoso, et al.
Publicado: (2020)